Racial/Ethnic Differences in Pathologic Complete Response to Neoadjuvant Chemotherapy and Survival Among Early-Stage, Erb-B2 Receptor Tyrosine Kinase 2-Low Breast Cancer Patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Racial/Ethnic Differences in Pathologic Complete Response to Neoadjuvant Chemotherapy and Survival Among Early-Stage, Erb-B2 Receptor Tyrosine Kinase 2-Low Breast Cancer Patients

Published:2024 Issue:1 Volume:27 Page:54
ISSN:1738-6756
Container-title:Journal of Breast Cancer
language:en
Short-container-title:J Breast Cancer

Author:

Freeman Jincong Q.¹²^ORCID,Li James L.¹³^ORCID,Omoleye Olasubomi J.⁴^ORCID

Affiliation:

1. Department of Public Health Sciences, The University of Chicago, Chicago, USA.

2. Cancer Prevention and Control Research Program, The University of Chicago Medicine Comprehensive Cancer Center, Chicago, USA.

3. Pritzker School of Medicine, The University of Chicago, Chicago, USA.

4. Department of Medicine, The University of Chicago, Chicago, USA.

Funder

Susan G. Komen

Publisher

XMLink

Link

https://ejbc.kr/pdf/10.4048/jbc.2023.0166

Reference18 articles.

1. Clinical outcomes of de novo metastatic HER2-low breast cancer: a National Cancer Database Analysis

2. Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update

3. Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer

4. NSABP B-47/NRG Oncology Phase III Randomized Trial Comparing Adjuvant Chemotherapy With or Without Trastuzumab in High-Risk Invasive Breast Cancer Negative for HER2 by FISH and With IHC 1+ or 2+

5. Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP